Source: International Congress 2015 – Cellular and molecular mechanisms of COPD and emphysema
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Thomas Conlon (Neuherberg, Germany), Thomas Conlon, Cornelia Prehn, Jerzy Adamski, Oliver Eickelberg, Ali Önder Yildirim. Elastase-induced emphysema is attenuated by L-carnitine supplementation. Eur Respir J 2015; 46: Suppl. 59, 5057

Member's Comments

No comment yet.

Related content which might interest you: Temporal profile of metaloproteases gene expression in elastase-induced emphysema Source: Annual Congress 2013 –Novel mechanisms in lung injury Year: 2013 Effect of MSC treatment on LPS-induced inflammation, emphysema and atherosclerosis in E3L mice Source: International Congress 2015 – The multiple facets of stem and progenitor cells in lung health and disease Year: 2015 Galectin-9 attenuates elastase-induced emphysema by reducing neutrophil chemotaxis in mice Source: International Congress 2016 – New signalling pathways in COPD Year: 2016 Acid sphingomyelinase deficiency improves lung function in allergen-induced asthma in mice Source: Annual Congress 2013 –Cell biology and murine models of asthma and inflammation Year: 2013 Mepenzolate bromide displays beneficial effects in a mouse model of chronic obstructive pulmonary disease Source: International Congress 2014 – Animal models in respiratory drug development Year: 2014 Animal models of pulmonary emphysema: a stereologist's perspective Source: Eur Respir Rev 2006; 15: 136-147 Year: 2006 Dilatation reserve of pulmonary arteries at stages of COPD experimental model Source: Annual Congress 2013 –Pulmonary circulation: animal models and experimental treatments Year: 2013 A novel non-human primate model of cigarette smoke-induced chronic obstructive pulmonary disease Source: International Congress 2014 – Animal models: asthma, COPD and beyond Year: 2014 The effect of lipopolysaccharide-contaminated ovalbumin on airway inflammation and remodeling in a chronic murine asthma model Source: Annual Congress 2013 –Murine models of lung immunology Year: 2013 Nintedanib reduces bleomycin-induced lung inflammation and fibrosis in mice Source: Annual Congress 2013 –Preclinical models for the development of new drugs for respiratory diseases Year: 2013 CHI-91040, a novel inhaled p38α inhibitor, counteracts lung inflammation induced by IL-1β in the rat Source: International Congress 2016 – ILD: from the bench to the bedside Year: 2016 High fructose intake increases alveolar enlargement and muscle inflammation in mice exposed to cigarette smoke Source: International Congress 2016 – New signalling pathways in COPD Year: 2016 Effects of tobacco smoke and poly IC, alone and in combination, on mouse lung pathology Source: Annual Congress 2013 –Preclinical models for the development of new drugs for respiratory diseases Year: 2013 LATE-BREAKING ABSTRACT: Research of large aperture fenestration emphysema model in pigs Source: International Congress 2016 – Clinical characteristics of asthma Year: 2016 Does Rosemary leaves extract can attenuate lung injury in experimental pulmonary fibrosis in rats? Source: International Congress 2016 – ILD pathogenesis Year: 2016 The role of lL-17 in the OVA-LPS driven model of lung inflammation Source: International Congress 2015 – Immune aspects of asthma and other airway diseases Year: 2015 PBI-compound, a novel first-in-class anti-fibrotic compound, reduces lung fibrosis in the bleomycin-induced lung fibrosis model: A comparative study with pirfenidone Source: Annual Congress 2013 –Preclinical models for the development of new drugs for respiratory diseases Year: 2013 Implication of interleukin-10 in the development of COPD induced by cigarette smoke exposure in mice Source: Annual Congress 2013 –COPD: experimental biology Year: 2013 Pharmacological profile and efficacy of GLPG1690, a novel ATX inhibitor for COPD treatment Source: International Congress 2015 – New targets and modalities for the treatment of asthma and COPD Year: 2015